The neutrophil –lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials

ConclusionThe NLR, an easily obtained inflammatory biomarker, independently predicts CV risk and all-cause mortality, and is reduced by interleukin-1 β blockade with canakinumab.
Source: European Heart Journal - Category: Cardiology Source Type: research